Sorry, you need to enable JavaScript to visit this website.

Trudell Medical Limited named one of Canada's Best Managed Companies for 2023

Read more

For the second year in a row, Trudell Medical Limited has been named one of Canada's Best Managed companies. 

Tagged: Trudell Medical Group, Trudell Medical Limited, Awards, News

Trudell Medical Limited was recognized for overall business performance and sustained growth with the prestigious Canada’s Best Managed Companies designation.

Tagged: Trudell Medical Group, Trudell Medical Limited, Awards, News

The Trudell Medical Group (TMG) located in Ontario, Canada, owns a portfolio of Canadian and US companies, bringing innovative medical devices and services to healthcare professionals and patients in over 110 countries. Within the portfolio, Trudell Medical International (Canada) and Monaghan Medical (US) are renowned for their market leading Aerochamber® and Aerobika® respiratory devices. ProResp is the leader in professional client-centered respiratory therapy for patients in local communities across the province of Ontario, Canada.

In January 2021, TMG took a big step into virtual care delivery, through the acquisition of Aetonix Systems, an Ottawa-based remote patient management platform.

Tagged: Aetonix, Monaghan Medical Corporation, Trudell Medical Group, ProResp, News, Press Release

Adherium Limited (ASX:ADR), a leader in digital inhaled device adherence, remote monitoring and data management solutions, is pleased to announce agreement of terms with leading respiratory company Monaghan Medical Corporation (Monaghan) to support the introduction of its Hailie® platform and technology into specialist respiratory centres in the United States

Tagged: Monaghan Medical Corporation, Trudell Medical Limited, Press Release

Trudell Medical Limited has invested in Adherium (Australia) as part of the company’s strategic plan to support organizations with innovative technologies that improve patient outcomes. Adherium is a provider of digital health solutions and a global leader in connected respiratory medical devices, with more than 170,000 sold globally. The company develops, manufactures and supplies a broad range of connected medical devices for respiratory medications for patients, pharmaceutical companies, healthcare providers and contract research organizations.  Trudell subscribed $1,126,000 million of secured debt notes. The funds raised from the issue will be used for working capital purposes.

Tagged: Trudell Medical Limited, News